Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Haemonetics to Buy Assets of Pall, Hemerus Medical

Haemonetics Corp. said it agreed to acquire the blood collection and filtration assets of Pall Corp. for approximately $551 million, and separately agreed to buy certain assets of Hemerus Medical LLC, a Minnesota-based company that develops technologies for the collection of whole blood, and processing and storage of blood components.

Haemonetics agreed to pay Pall $551 million, of which $536 million will be paid upon closing and the remaining $15 million paid for additional assets to be delivered by 2016, the statement said. Haemonetics said $475 million will be new borrowings and $61 million will be from existing cash holdings.

Haemonetics did not disclose the purchase price for the property of Hemerus.

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.